HOME >> BIOLOGY >> NEWS
Progress report on Homogeneous Assay project

International medical diagnostics company Panbio Limited today announced that it has achieved some encouraging results in the development of its Homogeneous Assay Technology.

The company's Advanced Technologies Division has developed a pair of pre-prototype assays for HSV-1 and HSV-2 antibody detection.* The key achievements of this development are:

  • The results obtained were based on real samples whereas, earlier in the project, results were based on a model assay; and
  • The results obtained were consistent with those obtained when using the current ELISA technology.

The company was also pleased that, at this early stage in the project, the results were obtained in less than 50% of the time taken on current ELISA technology.

The development of the assays has also enabled the project team to demonstrate that the design of the antigen used in the assay can have a positive impact on its performance despite the presence of potentially interfering substances in the sera used for testing.

Paul Nitz, Panbio Chief Executive Officer said, "We are pleased with the progress the project team has made. While a number of technical challenges remain, these results increase our confidence of reaching our next goal which is to produce a prototype assay for pre-clinical evaluation by the end of 2006."

Panbio will be presenting a poster at the American Association of Clinical Chemistry (AACC) meeting in Chicago on July 27 outlining the development of the Homogeneous Assay technology to date. The AACC meeting is one of the premier meetings in the world for the medical diagnostics industry. The company will be discussing the progress of the project with a number of potential licensees of the technology.


'"/>

Contact: Dr. Stuart Hazell
61-41-305-1601
Research Australia
21-Jul-2006


Page: 1

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress toward a targeted therapy for a specific form of leukemia
3. Progress against sarcoma
4. Progress toward artificial photosynthesis?
5. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
6. Progress in battle against life-threatening acute allergy
7. Progress being made in exploring potential use of stem cells to treat heart disease
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2019)... (PRWEB) , ... July 24, 2019 , ... ... that Donna Hartzfeld, PhD, a quality assurance expert with more than 20 years ... biologics, and combination products, has joined the firm as an Expert Consultant. , ...
(Date:7/23/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has received ... adipose-derived stem cells to treat their osteoarthritis. The first clinical trial, expected to begin ... , This is the first of several planned clinical trials which will enable ...
(Date:7/21/2019)... ... July 20, 2019 , ... ... announced today the release of the biggest software update in its history: ... will provide a significant increase in productivity for its users. , ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... 2019 , ... Quidel is the market leader in point-of-care ... and Siemens Healthineers and Response Biomedical also are among the top companies. The ... (POC) Diagnostics . , Quidel is a market leader in rapid immunoassays and ...
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/18/2019)... , ... June 17, 2019 , ... ... they have entered into an agreement for production and manufacturing of GMP-grade adeno-associated ... treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology ... the appointment of Biofeedback Tech Ltd as its authorised distributor for ... part of many therapeutic treatments and clinical assessment protocols to treat stress related ...
Breaking Biology Technology:
Cached News: